FDA Approved: GEMFIBROZIL — Supplemental Application (Northstar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for Gemfibrozil under Northstar RxLLC's ANDA, authorizing changes to the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• Gemfibrozil (Gemfibrozil)

Snippet

SUPPL AP for GEMFIBROZIL (GEMFIBROZIL)